JPWO2022200787A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022200787A5 JPWO2022200787A5 JP2023558498A JP2023558498A JPWO2022200787A5 JP WO2022200787 A5 JPWO2022200787 A5 JP WO2022200787A5 JP 2023558498 A JP2023558498 A JP 2023558498A JP 2023558498 A JP2023558498 A JP 2023558498A JP WO2022200787 A5 JPWO2022200787 A5 JP WO2022200787A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- methyl
- formula
- alkyl
- isobutyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2104033.2A GB202104033D0 (en) | 2021-03-23 | 2021-03-23 | New compounds |
| GB2104033.2 | 2021-03-23 | ||
| PCT/GB2022/050727 WO2022200787A1 (en) | 2021-03-23 | 2022-03-23 | Selective angiotensin ii receptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024511451A JP2024511451A (ja) | 2024-03-13 |
| JP2024511451A5 JP2024511451A5 (https=) | 2025-03-31 |
| JPWO2022200787A5 true JPWO2022200787A5 (https=) | 2025-03-31 |
Family
ID=75689748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558498A Pending JP2024511451A (ja) | 2021-03-23 | 2022-03-23 | 選択的アンジオテンシンｉｉ受容体リガンド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240197685A1 (https=) |
| EP (1) | EP4313977A1 (https=) |
| JP (1) | JP2024511451A (https=) |
| CN (1) | CN117242071A (https=) |
| CA (1) | CA3212188A1 (https=) |
| GB (1) | GB202104033D0 (https=) |
| WO (1) | WO2022200787A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE20230600A3 (en) | 2022-12-22 | 2025-09-24 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312820A (en) | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| YU78601A (sh) * | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
| KR100938817B1 (ko) * | 2001-05-31 | 2010-01-26 | 바이코어 파마 아베 | 안지오텐신 ⅱ 작용제로 유용한 삼중고리 화합물 |
| CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| WO2003064414A1 (en) * | 2002-01-29 | 2003-08-07 | Vicore Pharma Ab. | Tricyclic compounds useful as angiotensin ii agonists |
| WO2004046141A1 (en) | 2002-11-21 | 2004-06-03 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| BR112017012337A2 (pt) | 2014-12-12 | 2018-02-27 | Vicore Pharma Ab | Método para tratamento de doença falciforme, agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró- fármaco do mesmo, uso de um agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró-fármaco do mesmo, formulação farmacêutica, e, produto de combinação. |
| WO2016107879A2 (en) | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| CN107405406A (zh) | 2015-03-02 | 2017-11-28 | 维科尔药物公司 | 用于治疗肺纤维化的血管紧张素ii受体激动剂 |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| AR108906A1 (es) * | 2016-06-29 | 2018-10-10 | Bristol Myers Squibb Co | Heterociclos de biarilmetilo |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| KR20230004501A (ko) * | 2020-03-19 | 2023-01-06 | 바이코어 파마 아베 | 안지오텐신 ⅱ와 관련된 질병, 장애, 또는 병태의 치료 및/또는 예방에 유용한 신규 화합물 |
| GB202013721D0 (en) * | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
| GB202104038D0 (en) * | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
-
2021
- 2021-03-23 GB GBGB2104033.2A patent/GB202104033D0/en not_active Ceased
-
2022
- 2022-03-23 WO PCT/GB2022/050727 patent/WO2022200787A1/en not_active Ceased
- 2022-03-23 US US18/283,484 patent/US20240197685A1/en active Pending
- 2022-03-23 JP JP2023558498A patent/JP2024511451A/ja active Pending
- 2022-03-23 CA CA3212188A patent/CA3212188A1/en active Pending
- 2022-03-23 CN CN202280030668.3A patent/CN117242071A/zh active Pending
- 2022-03-23 EP EP22714511.7A patent/EP4313977A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021169499A5 (https=) | ||
| JP2024071370A5 (https=) | ||
| JP2013526494A5 (https=) | ||
| JP2021529746A5 (https=) | ||
| JP2021516240A5 (https=) | ||
| JP2007502264A5 (https=) | ||
| CN105960400A (zh) | 氨磺酰基噻吩酰胺衍生物及其作为药物用于治疗乙型肝炎的用途 | |
| JPWO2020092196A5 (https=) | ||
| JP2004532276A5 (https=) | ||
| JP2005524609A5 (https=) | ||
| JP2021529185A5 (https=) | ||
| JP2005529155A5 (https=) | ||
| HK1003137A1 (en) | New pyrazine derivatives, their preparation and their use | |
| KR20220133227A (ko) | 알파-1 항트립신 결핍증의 치료 방법 | |
| JP2020511450A5 (https=) | ||
| JPWO2021053344A5 (https=) | ||
| JP2010504322A5 (https=) | ||
| JPWO2022200787A5 (https=) | ||
| JPWO2020047447A5 (https=) | ||
| JPWO2020051105A5 (https=) | ||
| JPWO2020005888A5 (https=) | ||
| JPWO2022200786A5 (https=) | ||
| JPWO2020051139A5 (https=) | ||
| JPWO2022018186A5 (https=) | ||
| JPWO2020005887A5 (https=) |